Download Docs
Export

ALTHEOME

79451635 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Jan. 6, 2026
Serial No. 79451635
Examining Attorney DANIEL R SALTZMAN
Class Biotechnological research services; scientific research services; laboratory research services; laboratory testing services; design and product development services; scientific analysis services; biological research services; medical research services; research and development services; clinical trials; DNA sequencing for medical research and technology research purposes; biotechnological research services, scientific research services, laboratory research services, laboratory testing services, design and product development services, scientific analysis services, biological research services, medical research services, research and development services, clinical trials, and DNA sequencing for medical research and technology research purposes, all the aforesaid services relating to proteomics, proteomics profiling services, quantitative and qualitative protein analysis services, biomarker discovery, biomarker development, biomarker analysis, biomarker assays, discovery and development of biomarker assays, running samples for biomarkers across proteomics and genomics, genomic sequencing, the analysis of protein biomarkers, microbiome analysis, multigenomics, structural and functional analysis of genomes, disease diagnosis, treatment monitoring and disease risk assessment; biotechnological research services, scientific research services, laboratory research services, laboratory testing services, design and product development services, scientific analysis services, biological research services, medical research services, research and development services, clinical trials, and DNA sequencing for medical research and technology research purposes, all the aforesaid services relating to testing for viruses, bacteria, parasites, yeast and antimicrobial resistance genes in areas including respiratory, blood culture identification, gastrointestinal, meningitis, encephalitis, pneumonia and joint infection; biotechnological research services, scientific research services, laboratory research services, laboratory testing services, design and product development services, scientific analysis services, biological research services, medical research services, research and development services, clinical trials, and DNA sequencing for medical research and technology research purposes, all the aforesaid services relating to testing across respiratory infection, GI infection, STIs, vaginitis, meningitis, healthcare associated infection, COVID, tuberculosis, human papilloma infection, single nucleotide polymorphism, vector-borne disease, streptococcal infection, monkeypox, dermatophyte, urinary tract infection; design and development of diagnostic assays, devices, and platforms; research in the field of bioinformatics; research in the field of biostatistics; computerised data storage and database design services relating to bioinformatics and biostatistics; data and database services, namely design and development of computer database software for use in data analysis, data management, data hosting services, database development and maintenance, integration of data, data interpretation services, and curation and maintenance databases; computer modelling and computer simulation services; cloud computing services; design and development artificial intelligence and machine learning models; biological services, computer science services, and data analytics services, namely research in the field of bioinformatics, research in the field of biostatistics, data and database services, namely design and development of computer database software for use in data analysis, data management, data hosting services, database development and maintenance, integration of data, data interpretation services, and curation and maintenance databases, computer modelling and computer simulation services, cloud computing services, design and development artificial intelligence and machine learning models, all the aforementioned services relating to proteomics, proteomics profiling services, quantitative and qualitative protein analysis services, biomarker discovery, biomarker development, biomarker analysis, biomarker assays, discovery and development of biomarker assays, running samples for biomarkers across proteomics and genomics, genomic sequencing, the analysis of protein biomarkers, microbiome analysis, multigenomics, structural and functional analysis of genomes, disease diagnosis, treatment monitoring and disease risk assessment; biological services, computer science services, and data analytics services, namely research in the field of bioinformatic, research in the field of biostatistics, data and database services, namely design and development of computer database software for use in data analysis, data management, data hosting services, database development and maintenance, integration of data, data interpretation services, and curation and maintenance databases, computer modelling and computer simulation services, cloud computing services, design and development artificial intelligence and machine learning models, all the aforementioned services relating to testing for viruses, bacteria, parasites, yeast and antimicrobial resistance genes in areas including respiratory, blood culture identification, gastrointestinal, meningitis, encephalitis, pneumonia and joint infection; biological services, computer science services, and data analytics services, namely research in the field of bioinformatics, research in the field of biostatistics, data and database services, namely design and development of computer database software for use in data analysis, data management, data hosting services, database development and maintenance, integration of data, data interpretation services, and curation and maintenance databases, computer modelling and computer simulation services, cloud computing services, design and development artificial intelligence and machine learning models, all the aforesaid services relating to testing across respiratory infection, GI infection, STIs, vaginitis, meningitis, healthcare associated infection, COVID, tuberculosis, human papilloma infection, single nucleotide polymorphism, vector-borne disease, streptococcal infection, monkeypox, dermatophyte, urinary tract infection; information, advisory and consultancy services relating to the aforesaid.; 100; 101; 100; 101
ALTHEOME
Case Type Service mark
Status A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additional information and/or making an initial refusal. The applicant must respond to this Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Last Updated: 9 hours ago
Filing Date # Docket Text